Stockholm, Sweden – Xbrane (Nasdaq: XBRANE), a late-stage clinical biopharma company is inviting analysts, investors and media to the company’s Virtual Capital Markets Day on May 17th, 2021 at 14.00-15.30 CET.

The event will feature presentations from Xbrane’s Board and Management team outlining the company strategy and the next steps in the company's ambition to become a leading global biosimilar developer. The program will also include a virtual show of the recently established new development lab.

The event will start at 14.00 and will be broadcast live.

Please register using the following link;

https://tv.streamfabriken.com/xbrane-biopharma-cmd-2021

Xbrane BiopharmaAnders Tullgren, Chairman
The Biosimilar MarketMartin Åmark, CEO
Xlucane™Martin Åmark, CEO
Platform Technology & CapabilitiesDavid Vikström, Head of R&D
Virtual tour of the new Biotech labSiavash Bashiri, Deputy CEO
A world-leading Biosimilar DeveloperMartin Åmark, CEO
Wrap-up and Q&A sessionMartin Åmark, CEO

Agenda in brief:

Participants are invited to ask questions to IR@xbrane.com or live during the event.

Recordings of the presentations, and the presentations themselves, will be made available on the website www.xbrane.com.

© Modular Finance, source Nordic Press Releases